Unpacking the New Expert Consensus Panel Recommendations on the Use of Deucravacitinib (Sotyktu, BMS) in Psoriasis
Lab monitoring is not required for psoriasis patients treated with deucravacitinib (Sotyktu, BMS), according to a new expert consensus panel. In this video, study author Milaan Shah, MD, a Dermatology Resident at the Medical University of South Carolina in Charleston, SC, reviews the findings , which are published in the February 2025 issue of the […]